TP53 and neoplasm: When PFN-α was used to treat HGC27 (Fig. 5c) and HGC27/L (Fig. 5d), it was found that PFN-α could promote the survival of tumor cells, which was considered to be related to the inhibition of the expression of tumor suppressor gene p53 by PFN-α.